Animesh Pardanani

发表论文 44 篇 · 总被引 137 次 · h-index 4

代表论文

• Post‐FDA Approval Experience With Momelotinib in JAK Inhibitor‐Naïve Myelofibrosis: Focus on Anemia Response and Treatment‐Emergent Nephropathy and Peripheral Neuropathy (2025 · American journal of hematology/oncology · 被引 5)
• Predictors of response to pacritinib therapy and survival among 60 Mayo Clinic patients with myelofibrosis treated outside of clinical trials (2025 · Haematologica · 被引 3)
• Validation of BLAST and BLAST‐Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo–Humanitas Collaborative Project Involving 1101 Patients (2025 · American journal of hematology/oncology · 被引 2)
• Myeloproliferative Neoplasms‐Unclassifiable (MPN‐U): A Carefully Curated Series of 30 Mayo Clinic Patients (2025 · American journal of hematology/oncology · 被引 2)
• Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome (2026 · Blood Cancer Journal · 被引 1)
• TP53 Mutations and Circulating Blasts ≥ 20% Are the Primary Determinants of Survival in Accelerated/Blast‐Phase Myeloproliferative Neoplasms Treated With Frontline Venetoclax Plus Hypomethylating Agent (2026 · American journal of hematology/oncology · 被引 1)